Document is current

Article History

Received: 4 December 2017

Accepted: 17 May 2018

First Online: 31 May 2018

Authors’ information

: BS conducted the original efficacy trial upon which this study was based. BS has written extensively on the topic of post cessation weight gain, published a seminal review of the literature on combined smoking and weight treatments and also on behavioral weight management interventions.JL was an investigator on the successful and highly influential Diabetes Prevention Program that established a lifestyle intervention was superior to medication in delaying or preventing onset of Type 2diabetes.

: The Western Institutional Review Board and the State of Maryland Institutional Review Board – in accordance with the United States legislation gave consent for the study. Participant consent was obtained verbally via the phone and documented by trained staff. The tobacco cessation and weight management programs are overseen by a clinical team at Alere Wellbeing. All study participants were 18 years of age or older. Alere is a HIPAA covered entity and complies with all HIPAA regulations regarding data security.

: The authors at Alere Wellbeing declare that they are employed by Alere Wellbeing (a subsidiary of Optum) which provides tobacco cessation and weight management services to states and commercial clients. They have no other competing interests.JL declares that she has no competing interests.HJ declares that he has no competing interests.BS declares that she has no competing interests.MT declares that she has no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.